TIE2 Inhibitors Having a Cyclic Structure and Uses Thereof
TW202637169APending Publication Date: 2026-09-16SHANGHAI HAIHE PHARMACEUTICAL CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- TW115105853
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-02-14
- Filing Date
- 2026-02-12
- Publication Date
- 2026-09-16
Abstract
The present invention relates to a class of TIE2 inhibitors having a cyclic structure and uses thereof. The TIE2 inhibitors having a cyclic structure possess a structure represented by Formula (I ).The compounds of the general formula of the present invention exhibit high selectivity for TIE2 inhibition across a broad kinase panel. In BaF3-FL-TIE2 L914F cells highly expressing the TIE2 L914F protein, the compounds demonstrate significant anti-proliferative activity.Accordingly, the compounds can be used for the treatment of disorders or diseases mediated by TIE2, such as disorders or diseases associated with TEK gene abnormalities or aberrant protein activity.
Need to check novelty before this filing date? Find Prior Art